{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:35:30Z","timestamp":1783398930576,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ando.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T19:20:20Z","timestamp":1682104820000},"page":"430-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-0653","authenticated-orcid":false,"given":"Victor","family":"Vermot-Desroches","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Thia-Soui-Tchong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Orgiazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jouanneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Froment Tilikete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Manet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Abeillon Du Payrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2023.04.002_bib0260","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.04.002_bib0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17469899.2017.1276444","article-title":"Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management","volume":"12","author":"Blandford","year":"2017","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0270","series-title":"StatPearls [Internet]","article-title":"Dysthyroid optic neuropathy","author":"Agarwal","year":"2021"},{"key":"10.1016\/j.ando.2023.04.002_bib0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2011.10.005","article-title":"Epidemiology of Graves\u2019 orbitopathy (GO) and relationship with thyroid disease","volume":"26","author":"Lazarus","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.04.002_bib0280","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40618-020-01361-y","article-title":"Dysthyroid optic neuropathy: evaluation and management","volume":"44","author":"Dolman","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.04.002_bib0285","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/IOP.0000000000001146","article-title":"Dysthyroid optic neuropathy","volume":"34","author":"Saeed","year":"2018","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ando.2023.04.002_bib0290","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/IOP.0000000000001150","article-title":"Grading severity and activity in thyroid eye disease","volume":"34","author":"Dolman","year":"2018","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ando.2023.04.002_bib0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/IOP.0000000000001501","article-title":"Optic nerve stretch is unlikely to be a significant causative factor in dysthyroid optic neuropathy","volume":"36","author":"Rose","year":"2020","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.ando.2023.04.002_bib0300","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bjo.80.12.1042","article-title":"Retrobulbar pressures measured during surgical decompression of the orbit","volume":"80","author":"Otto","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0305","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2006.094607","article-title":"Clinical features of dysthyroid optic neuropathy: a European Group on Graves\u2019 Orbitopathy (EUGOGO) survey","volume":"91","author":"McKeag","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0310","first-page":"1555","article-title":"A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom","volume":"32","author":"Wong","year":"2018","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.ando.2023.04.002_bib0315","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cen.13880","article-title":"Sight-threatening Graves\u2019 orbitopathy: twenty years\u2019 experience of a multidisciplinary thyroid-eye outpatient clinic","volume":"90","author":"Tramunt","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.04.002_bib0320","first-page":"1702","article-title":"Evaluation of medical and surgical decompression in patients with dysthyroid optic neuropathy","volume":"34","author":"Garip-Kuebler","year":"2020","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.ando.2023.04.002_bib0325","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/thy.1998.8.427","article-title":"Clinical presentation of thyroid associated orbitopathy","volume":"8","author":"Kendall-Taylor","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2023.04.002_bib0330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the management of Graves\u2019 orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2023.04.002_bib0335","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves\u2019 orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.04.002_bib0340","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/thy.2013.0445","article-title":"Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy","volume":"24","author":"Curr\u00f2","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2023.04.002_bib0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archopht.1968.03850040281009","article-title":"Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction","volume":"79","author":"Day","year":"1968","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0350","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12886-020-1314-8","article-title":"Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy","volume":"20","author":"Tagami","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0355","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/thy.2010.1634","article-title":"Risk factors for development or deterioration of Graves\u2019 ophthalmopathy","volume":"20","author":"Stan","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2023.04.002_bib0360","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2015-4294","article-title":"Risk factors for Graves\u2019 orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study","volume":"101","author":"Khong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.04.002_bib0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.04.002_bib0370","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiology.177.3.2243967","article-title":"Graves orbitopathy: correlation of CT and clinical findings","volume":"177","author":"Nugent","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2023.04.002_bib0375","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1148\/radiology.167.2.3357962","article-title":"Optic nerve dysfunction in thyroid eye disease: CT","volume":"167","author":"Barrett","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2023.04.002_bib0380","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.200.1.8657899","article-title":"Graves ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression","volume":"200","author":"Birchall","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2023.04.002_bib0385","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.04.002_bib0390","doi-asserted-by":"crossref","first-page":"E1059","DOI":"10.1093\/neuros\/nyz268","article-title":"Minimal-access endoscopic endonasal management of dysthyroid optic neuropathy: the Dysthone Study","volume":"85","author":"Zah-Bi","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2023.04.002_bib0395","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0161-6420(88)32978-7","article-title":"Dysthyroid optic neuropathy. The crowded orbital apex syndrome","volume":"95","author":"Neigel","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ando.2023.04.002_bib0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3341\/kjo.2012.26.2.73","article-title":"Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy","volume":"26","author":"Jeon","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0405","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/IIO.0000000000000101","article-title":"Thyroid eye disease: optic neuropathy and orbital decompression","volume":"56","author":"Victores","year":"2016","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ando.2023.04.002_bib0410","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5603\/EP.a2016.0018","article-title":"Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy","volume":"67","author":"Mi\u015bkiewicz","year":"2016","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.ando.2023.04.002_bib0415","doi-asserted-by":"crossref","first-page":"9323450","DOI":"10.1155\/2020\/9323450","article-title":"The therapeutic effect of combination of orbital decompression surgery and methylprednisolone pulse therapy on patients with bilateral dysthyroid optic neuropathy","volume":"2020","author":"Xu","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0420","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.18240\/ijo.2021.07.21","article-title":"Therapeutic difference between orbital decompression and glucocorticoids administration as the first-line treatment for dysthyroid optic neuropathy: a systematic review","volume":"14","author":"Xu","year":"2021","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0425","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bjo.83.4.463","article-title":"Diabetes mellitus: a risk factor in patients with Graves\u2019 orbitopathy","volume":"83","author":"Kalmann","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0430","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/IOP.0000000000001871","article-title":"Sight-threatening thyroid eye disease: role of diabetes mellitus and interaction with other risk factors","volume":"37","author":"Rath","year":"2021","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ando.2023.04.002_bib0435","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves\u2019 ophthalmopathy","volume":"12","author":"Bartalena","year":"1989","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.04.002_bib0440","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3341\/kjo.2010.24.5.267","article-title":"Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients","volume":"24","author":"Lee","year":"2010","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0445","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s40618-020-01258-w","article-title":"Asymmetry indicates more severe and active disease in Graves\u2019 orbitopathy: results from a prospective cross-sectional multicentre study","volume":"43","author":"Perros","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.04.002_bib0450","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IOP.0000000000000699","article-title":"Thyroid-related orbital decompression surgery: a multivariate analysis of risk factors and outcomes","volume":"33","author":"Wu","year":"2017","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ando.2023.04.002_bib0455","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/IOP.0b013e3181c9bb52","article-title":"Anatomy-based surgical concepts for individualized orbital decompression surgery in graves orbitopathy. I. Orbital size and geometry","volume":"26","author":"Kamer","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ando.2023.04.002_bib0460","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0002-9394(14)70439-8","article-title":"Chronology of Graves\u2019 ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0465","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41433-018-0259-0","article-title":"Evolution of thyroid eye disease decompression\u2014dysthyroid optic neuropathy","volume":"33","author":"Tooley","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.ando.2023.04.002_bib0470","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ajo.2006.01.066","article-title":"Medial wall decompression for optic neuropathy but lateral wall decompression with fat removal for non vision-threatening indications","volume":"141","author":"McCann","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0475","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00005537-200303000-00021","article-title":"Endoscopic and transconjunctival orbital decompression for thyroid-related orbital apex compression","volume":"113","author":"Schaefer","year":"2003","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.ando.2023.04.002_bib0480","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lary.20240","article-title":"Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy","volume":"119","author":"Chu","year":"2009","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.ando.2023.04.002_bib0485","doi-asserted-by":"crossref","first-page":"3537675","DOI":"10.1155\/2020\/3537675","article-title":"Strategies in surgical decompression for thyroid eye disease","volume":"2020","author":"Cheng","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ando.2023.04.002_bib0490","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ajo.2005.12.010","article-title":"Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy","volume":"141","author":"Liao","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ando.2023.04.002_bib0495","doi-asserted-by":"crossref","first-page":"e24513","DOI":"10.1097\/MD.0000000000024513","article-title":"Comparison of 2-wall versus 3-wall orbital decompression against dysthyroid optic neuropathy in visual function: a retrospective study in a Chinese population","volume":"100","author":"Cheng","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2023.04.002_bib0500","first-page":"275","article-title":"Methylprednisolone pulse therapy for patients with dysthyroid optic neuropathy","volume":"20","author":"Mourits","year":"2001","journal-title":"Orbit Amst Neth"},{"key":"10.1016\/j.ando.2023.04.002_bib0505","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2005.02345.x","article-title":"Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves\u2019 ophthalmopathy? A randomized controlled trial","volume":"63","author":"Wakelkamp","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.04.002_bib0510","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1097\/IOP.0000000000001831","article-title":"Teprotumumab for dysthyroid optic neuropathy: early response to therapy","volume":"37","author":"Sears","year":"2021","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:54:46Z","timestamp":1757717686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426623000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0003426623000793"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2023.04.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}